3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, T-Cell, Peripheral
5
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, T-Cell
3
Lymphoma
2
Immunoblastic Lymphadenopathy
2
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Mycosis Fungoides
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Prolymphocytic, T-Cell
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
4
Prednisone
3
Etoposide
3
Doxorubicin
3
etoposide phosphate
2
Vincristine
2
Brentuximab Vedotin
2
tazemetostat
1
prednylidene
1
pembrolizumab
1
fludarabine
1
duvelisib
1
deltacortene
1
Prednisolone
1
Melphalan
1
Cytarabine
1
Cholecalciferol
1
Carmustine
1
Azacitidine
1
10-propargyl-10-deazaaminopterin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Enteropathy-Associated T-Cell Lymphoma
×
romidepsin
×
1 year
×
Clear all
No trials found.